GHP Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
GHP Investment Advisors's NVO Position: Q2 2026 in Review
GHP Investment Advisors reduced its Novo Nordisk (NVO) stake by 0.72% in Q2 2026, selling an estimated $1.5K and leaving 4,826 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #385.
GHP Investment Advisors first reported a position in NVO in Q3 2021 and has held it in 20 quarters since. The position peaked at $670K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- GHP Investment Advisors held 4,826 shares of Novo Nordisk worth $231K as of Q2 2026.
- GHP Investment Advisors sold 35 Novo Nordisk shares in Q2 2026, an estimated $1.5K.
- Novo Nordisk made up 0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #385 holding.
- GHP Investment Advisors first reported a position in Novo Nordisk in Q3 2021 and has held it in 20 quarters since.
- GHP Investment Advisors's Novo Nordisk position peaked at $670K in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.